Detalhe da pesquisa
1.
Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated Vaccine.
J Infect Dis
; 227(2): 251-255, 2023 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108092
2.
Standard-dose versus MF59-adjuvanted, high-dose or recombinant-hemagglutinin influenza vaccine immunogenicity in older adults: comparison of A(H3N2) antibody response by prior season's vaccine status.
J Infect Dis
; 2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37950884
3.
Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine.
Clin Infect Dis
; 76(3): e299-e307, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35675370
4.
Biphasic Waning of Hemagglutination Inhibition Antibody Titers After Influenza Vaccination in Children.
J Infect Dis
; 226(6): 1022-1026, 2022 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35380689
5.
Immunogenicity, efficacy, and safety of SARS-CoV-2 vaccine dose fractionation: a systematic review and meta-analysis.
BMC Med
; 20(1): 409, 2022 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36284331
6.
Investigation of CD4 and CD8 T cell-mediated protection against influenza A virus in a cohort study.
BMC Med
; 20(1): 230, 2022 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35858844
7.
Viral RNA and Infectious Influenza Virus on Mobile Phones of Patients With Influenza in Hong Kong and the United States.
J Infect Dis
; 224(10): 1730-1734, 2021 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534320
8.
Upper Respiratory Infections in Schools and Childcare Centers Reopening after COVID-19 Dismissals, Hong Kong.
Emerg Infect Dis
; 27(5): 1525-1527, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33596168
9.
Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults.
J Infect Dis
; 222(8): 1383-1391, 2020 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32407535
10.
Presence of Influenza Virus on Touch Surfaces in Kindergartens and Primary Schools.
J Infect Dis
; 222(8): 1329-1333, 2020 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32179916
11.
Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial.
Clin Infect Dis
; 71(7): 1704-1714, 2020 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31828291
12.
Distinguishing Causation From Correlation in the Use of Correlates of Protection to Evaluate and Develop Influenza Vaccines.
Am J Epidemiol
; 189(3): 185-192, 2020 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31598648
13.
Controversy around airborne versus droplet transmission of respiratory viruses: implication for infection prevention.
Curr Opin Infect Dis
; 32(4): 372-379, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31259864
14.
Role of viral bioaerosols in nosocomial infections and measures for prevention and control.
J Aerosol Sci
; 117: 200-211, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32226118
15.
Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the Community.
Clin Infect Dis
; 64(6): 736-742, 2017 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011603
16.
Review Article: The Fraction of Influenza Virus Infections That Are Asymptomatic: A Systematic Review and Meta-analysis.
Epidemiology
; 26(6): 862-72, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26133025
17.
High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains.
bioRxiv
; 2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38496577
18.
Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children.
Nat Commun
; 15(1): 3210, 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38615070
19.
Preliminary findings from the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: a Randomized Controlled Trial.
medRxiv
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38798684
20.
Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial.
Lancet Microbe
; 4(9): e670-e682, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549680